Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

UTI Mutual Fund : UTI Dividend Yield Fund declares tax free dividend of 5%

06/14/2013 | 09:18am US/Eastern

PRESS RELEASE

UTI Dividend Yield Fund declares tax-free dividend of 5%
UTI Dividend Yield Fund declares tax-free dividend of 5% (Re.0.50 per unit on face value of Rs.10) under dividend option-existing plan. Pursuant to the payment of dividend, the NAV of the dividend option-existing plan of the scheme would fall to the extent of payout.
The record date for the dividend is June 19, 2013.
All unit holders registered under the dividend option-existing plan of UTI Dividend Yield Fund as on the record date will be eligible for this dividend. Also investors who join the dividend option-existing plan of the scheme on or before the cut off time of the record date will be eligible for the dividend.
The NAV of UTI Dividend Yield Fund on June 13, 2013 under dividend option-existing plan was Rs.12.9103.
UTI-Dividend Yield Fund is an open-ended equity oriented scheme. The investment objective of the scheme is to provide medium to long-term capital gains and / or dividend distribution by investing predominantly in equity and equity related instruments, which offer high dividend yield. Dividend Yield may be considered as high if it is greater than the dividend yield of the Nifty last released/ published by NSE.
Ms Swati Kulkarni is the fund manager of the scheme.
About UTI Mutual Fund
UTI Mutual Fund is a SEBI registered mutual fund whose Sponsors are State Bank of
India, Punjab National Bank, Bank of Baroda and Life Insurance Corporation of India.
UTI Mutual Fund is one of the largest mutual funds in India with investor accounts of
9.73 million under its 91 domestic schemes / plans as on May 31, 2013.

Sponsors: State Bank of India, Punjab National Bank, Bank of Baroda, Life Insurance Corporation of India

Corporate Office: UTI Tower, 'Gn' Block, Bandra-Kurla Complex, Bandra (East), Mumbai 400 051. Tel: 6678 6666

Website:www.utimf.com

PRESS RELEASE

Mumbai
June 14, 2013

Registered Office: UTI Tower, 'Gn' Block, Bandra - Kurla Complex, Bandra (E), Mumbai
- 400 051. Phone : 022-66786666. For more information please contact the nearest UTI Financial Centre or your AMFI/NISM certified UTI Mutual Fund independent Financial Advisor (IFA) for a copy of Statement of Additional Information, Scheme Information Document and Key Information Memorandum cum Application Form. Mutual Fund Investments are subject to market risks, read all scheme related
documents carefully

Sponsors: State Bank of India, Punjab National Bank, Bank of Baroda, Life Insurance Corporation of India

Corporate Office: UTI Tower, 'Gn' Block, Bandra-Kurla Complex, Bandra (East), Mumbai 400 051. Tel: 6678 6666

Website:www.utimf.com

distributed by
React to this article
Latest news
Date Title
09:03aDJMARKET SNAPSHOT : Apple, Energy, Health Care Earnings To Dominate Week
09:01a JPMORGAN CHASE : Third Annual Chase Sapphire Preferred Grill Challenge Turns up the Heat with Celebrity Chefs Emeril Lagasse and Michael Mina during Vegas Uncork’d by Bon Appétit
08:59a SAUDI PHARMACEUTICAL INDUST&MDCL APPLNCS : Spimaco announces the results of the ordinary general assembly meeting
08:59a DEUTSCHE BANK : reports first quarter 2015 net income of EUR 559 million
08:55a GROW CONDOS : Budding Opportunity
08:54a CORELOGIC : Foreclosures trending downward in Middle Georgia, the nation
08:43a UNDER ARMOUR : Cooper's Casey, Fortune raise game to reach state golf tournament
08:42a NISSAN MOTOR : BRIEF: 2 injured in wreck at Fairview
08:37a WISC PUB5PF : FERC Receives Electric Rate Filing from Wisconsin Public Service
08:37a LEXMARK : Rep. Barr Issues Statement Recognizing Lexmark as Industry Leader in Field of Sustainability
Latest news
Advertisement
Hot News 
GCP STUDENT LIVING : Dividend Declaration and Net Asset Valuation
AERIE PHARMACEUTICALS : Pharma plunges aftermarket as Rhopressa study fails
SYQIC : Gets Working Capital Facility Offer, Improves Cash Position
INNATE PHARMA : and AstraZeneca announce global agreement for IPH2201 in immuno-oncology
French Connection warns on full-year results
Most Read News
04/25 DEUTSCHE BANK : to keep 500 German retail branches - Welt am Sonntag
04/25 MANCHESTER UNITED : United aiming to win title next year
04/25 KROGER : accounting celebrates 20 years of growth in Hutchinson
05:27aDJGOOGLE : Correction to Mount Everest Avalanche Story
04/25 SOLARCITY : Town of Plattsburgh exploring solar project
Most recommended articles
09:03aDJMARKET SNAPSHOT : Apple, Energy, Health Care Earnings To Dominate Week
08:23a ECB's Liikanen warns of asset price bubbles due to low interest rates
08:19a Pop Milano sits pretty as Italy cooperative banks brace for M&A
08:10a SEC's stock market reform club locks out retail brokers
08:05a CHARLES SCHWAB : Analysis - SEC's stock market reform club locks out retail brokers
Dynamic quotes  
ON
| OFF